Intracranial Hemorrhages
83
14
17
33
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.6%
3 terminated out of 83 trials
91.7%
+5.2% vs benchmark
22%
18 trials in Phase 3/4
12%
4 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (83)
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE)
Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH)
Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Neonatal Seizure Registry - Developmental Functional EValuation
Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients
Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)
AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
A Pilot Study on the Prevention of the Vascular RISK Related to Atrial Fibrillation After Intracranial Hemorrhage by Closing the Left Auricle
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Screening Emotions in Adolescents at the Hospital for mTBI
Safety and Efficacy of Aneurysms Treated With Endovascular Devices
Intracranial PrEssure Time dOse (ImPETO)
Thrombolysis in Factor Xa-inhibitors Trial
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)
Statins for Treatment of Primary Intracerebral Hemorrhage
Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes
PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)